Resources
Research and analysis plan – Evidence to support the HTA Review
This infographic provides a plan for the research and analysis that will inform the HTA Policy and Methods Review.
Alcohol and Other Drugs – National quality framework mapping standards refresh
The National Quality Framework for Drug and Alcohol Treatment Services sets a national quality benchmark which consumers can expect from alcohol and other drug treatment providers.
Consultation to Inform Funding for Alcohol and Other drug treatment services to support CDC trial participants
This report outlines the findings to inform the grant funding decision-making process for the delivery of alcohol and other drug treatment services for four Cashless Debit Card (CDC) trial sites: Ceduna (SA), Bundaberg-Hervey Bay (QLD), East Kimberley and the Goldfields (WA).
3:59
BreastScreen Australia – Why screen?
Listen to the stories of Judith, Julie, Clare and Merlinda on how early breast cancer screening saved their lives.
Health Technology Assessment Policy and Methods Review – Reference committee meeting agenda – 19 December 2022
Health Technology Assessment Policy and Methods Review Reference Committee agenda for the 2nd meeting on 19 December 2022.
Health Technology Assessment Policy and Methods Review Reference Committee Communique – 27 January 2023 meeting
An update from the Health Technology Assessment Policy and Methods Review Reference Committee following its meeting on 27 January 2023.
Health Technology Assessment Policy and Methods Review – Reference committee meeting agenda – 13 February 2023
Health Technology Assessment Policy and Methods Review Reference Committee agenda for the 4th meeting on 13 February 2023.
Health Technology Assessment Policy and Methods Review – Reference committee meeting agenda – 1 December 2022
Health Technology Assessment Policy and Methods Review Reference Committee agenda for the 1st meeting on 1 December 2022.
AODconnect app
AODconnect is a national directory of alcohol and other drug treatment services for Aboriginal and Torres Strait Islander peoples. The app is available on iOS and Android devices.
0:28
Experimenting with ice? Get help now
As a counsellor, Mikel has seen the damage that drugs like ice can do. But with the right help, people can create better lives for themselves.
The sooner you get help, the sooner you can take your life back from ice.
The sooner you get help, the sooner you can take your life back from ice.
Cracks in the ice app
The Cracks in the ice app provides trusted, evidence-based, and up-to-date information and resources about crystal methamphetamine (ice) for the Australian community.
0:15
Get ready parents, kids want to talk to you about drugs
Did you know 1 in 3 kids say they’d turn to their parents for advice about drugs? Make sure you’re ready for that conversation.
0:30
Stephanie’s story: Did you know caps can trigger depression?
Drugs. The risks are real. Stephanie partied hard at uni. She had no idea caps could trigger depression. “It’s gonna be a long struggle to get back,” she said.
0:15
Where do kids go for advice about drugs?
Did you know 1 in 3 kids say they’d turn to their parents for advice about drugs? Make sure you’re ready for that conversation.
0:30
Tom’s story: he never thought a party drug could hurt him
Drugs. The risk are real. Tom’s mother recalls how her son thought sneaking into a club was just another adventure. He never thought caps would hurt him. But they did. He died on the way to the hospital.
Health Technology Assessment Review – Frequently Asked Questions
Frequently asked questions about the Health Technology Assessment Policy and Methods Review.
Budget 2022–23: Addressing the impact of alcohol and other drugs
A Budget 2022–23 fact sheet.
Evaluation of the Pharmaceutical Benefits Scheme subsidised take home naloxone pilot
This report presents the final evaluation findings, covering the pilot in NSW, SA and WA from commencement on 1 December 2019 up until 30 June 2021.
ANACAD summary of activities 2020–21
An overview of activities by the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) from 1 July 2020 to 30 June 2021.
ANACAD summary of activities 2019–20
An overview of activities by the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) from 1 July 2019 to 30 June 2020.
Evaluation of the National Ice Action Strategy (NIAS)
This document is a response to the findings of the National Ice taskforce in 2015. This report provides a comprehensive assessment of the NIAS.
Opioid Prescribing Practices Project - Key Outcomes
This report outlines the findings of a randomised controlled trial (RCT) conducted by the Department of Health. The RCT explored whether a letter designed with behavioural insights principles would help GPs reflect on their opioid prescribing.
Certification statement – Safe and effective use of prescription opioids campaign
This certificate of compliance, signed by Secretary Brendan Murphy, certifies that the safe and effective prescription opioids campaign complies with relevant guidelines and policies.
Real Time Prescription Monitoring public summary of the Privacy Impact Assessment
The Real Time Prescription Monitoring (RTPM) Privacy Impact Assessment (PIA) was conducted to ensure the Nation Data Exchange (NDE) system contained the appropriate obligations and protections in relation to the collection and storage of individual personal information.
National Drug Strategy 2018 Annual Report
This Annual Report is consistent with the National Drug Strategy 2017–2026.
ANACAD summary of activities 2018–19
An overview of activities by the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) from 1 July 2018 to 30 June 2019.
National Framework for Alcohol, Tobacco and Other Drug Treatment 2019–29
This framework’s aim is that all Australians seeking alcohol and other drug treatment can access high quality treatment appropriate to their needs, when and where they need it. It includes principles for effective treatment, monitoring and evaluation.
MDAF communique – 28 November 2019
A summary of the major items discussed at the fifth MDAF meeting.
National Quality Framework for Drug and Alcohol Treatment Services
This framework sets a nationally consistent quality benchmark for providers of drug and alcohol treatment services. It includes strong clinical governance requirements and a list of accreditation standards that drug and alcohol specialist treatment service providers must meet.
Trends in substance use among Australian secondary school students 1996–2017
This report presents trends data of the Australian Secondary Students' Alcohol and Drug (ASSAD) survey. It includes statistics on the use of tobacco, alcohol, electronic cigarettes, over-the-counter drugs, and illicit drugs, 1996–2017.
Secondary school students’ use of tobacco, alcohol and other drugs in 2017
This report presents the results of the Australian Secondary Students’ Alcohol and Drug (ASSAD) survey. It includes statistics on the use of tobacco, alcohol, electronic cigarettes, over-the-counter drugs, and illicit drugs.
ANACAD summary of activities 2017–18
An overview of activities by the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) from 1 July 2017 to 30 June 2018.
MDAF communique – 14 June 2018
A summary of the major items discussed at the fourth MDAF meeting.
National Drugs Campaign Evaluation Research May 2018
This report evaluates the seventh phase of the National Drugs Campaign.
ANACAD summary of activities 2016–17
An overview of activities by the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) from 1 July 2016 to 30 June 2017.
MDAF communique – 27 November 2017
A summary of the major items discussed at the third MDAF meeting.
National Drugs Campaign Evaluation Research August 2015
This report evaluates wave one of the Ice Destroys Lives phase of the National Drugs Campaign.
National Drugs Campaign Evaluation Research March 2016
This report evaluates wave two of the Ice Destroys Lives phase of the National Drugs Campaign.
Community Attitude Research on Alcohol and other Drugs – Summary Report
The summary of the Community Research on Alcohol and other Drugs report was developed to inform future alcohol and other drugs policy and planning.
Community Attitude Research on Alcohol and other Drugs – Quantitative Report
This quantitative Community Research on Alcohol and other Drugs report was developed to inform future alcohol and other drugs policy and planning.
Community Attitude Research on Alcohol and other Drugs – Qualitative Report
This qualitative Community Research on Alcohol and other Drugs report was developed to inform future alcohol and other drugs policy and planning.
National Drug Strategy 2017–2026
A ten-year framework that aims to reduce and prevent the harmful effects of alcohol, tobacco and other drugs.
MDAF communique – 29 May 2017
A summary of the major items discussed at the second MDAF meeting.
ANACAD summary of activities 2015–16
An overview of activities by the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) from December 2014 to 30 June 2016.
Community attitude research on alcohol and other drugs – executive report
Research into community attitudes and behaviour about illicit drug use was done to inform future policy and planning for alcohol and other drug issues. This summary report presents an overview of the findings.
MDAF communique – 16 December 2016
A summary of the major items discussed at the first MDAF meeting.
Community attitude research on alcohol and other drugs – quantitative report
Research into community attitudes and behaviour about illicit drug use was done to inform future policy and planning for alcohol and other drug issues. This report outlines the quantitative research that was done and the results.
Secondary school students’ use of tobacco, alcohol and other drugs in 2014
This report presents the results of the Australian Secondary Students’ Alcohol and Drug (ASSAD) survey. It includes statistics on the use of tobacco, alcohol, electronic cigarettes, over-the-counter drugs, illicit drugs and health services.
Community attitude research on alcohol and other drugs – qualitative report
Research into community attitudes and behaviour about illicit drug use was done to inform future policy and planning for alcohol and other drug issues. This report outlines how the qualitative research was done and the results.
Taking action to combat ice
Australian Government response to the National Ice Taskforce final report
National Ice Action Strategy 2015
This strategy aims to reduce the use and harmful effects of ice in Australia.
Cape York Wellbeing Centres Evaluation Report
An evaluation from 2012 to 2014 assessed the Cape York Wellbeing Centres. It looked at whether the centres reduced alcohol and substance abuse and harm in the community. This 2014 report presents the findings.
New Horizons: review of alcohol and other drug treatment services
This 2014 report describes the alcohol and other drug (AOD) treatment system and funding processes in Australia. It provides options for future funding that respond to the needs of individuals, families and communities.
National Alcohol and Other Drug Workforce Development Strategy 2015–2018
This strategy aims to improve the skills of the alcohol and other drug (AOD) workforce and prepare them for the future.
Study of Patient Pathways in Alcohol and Other Drug Treatment
This 2014 study analyses patient journeys through drug and alcohol treatment services. It describes the different parts of the drug and alcohol systems. It also looks at how the different parts connect.
National guidelines for medication-assisted treatment of opioid dependence
These guidelines for health professionals outline medications available for treating opioid dependence in Australia. They are intended for use by those not experienced in the treatment of alcohol and other drug problems.
National Aboriginal and Torres Strait Islander Peoples Drug Strategy 2014–2019
This strategy aims to reduce the harmful effects alcohol and other drugs in Aboriginal and Torres Strait Islander communities.
The impact of the revised Opioid prescribing changes from 1 June 2020 webinar
This webinar hosted by Prof. Michael Kidd AM focuses on the impact of the revised Opioid prescribing changes from 1 June 2020. The expert panel will provide information and answer participants’ questions.
Last updated: